The cancer-linked phenotype of Vav2/Vav3-deficient mice is also quite different from that previously reported for Tiam1-deficient mice during both tumor initiation [4],[5] and papilloma/cSCC malignant progression [4]. Here, VAV2 is linked to neoplasm.